Logo image of PRM

PERIMETER SOLUTIONS INC (PRM) Stock Fundamental Analysis

NYSE:PRM - New York Stock Exchange, Inc. - US71385M1071 - Common Stock - Currency: USD

12.24  +0.27 (+2.26%)

Fundamental Rating

5

PRM gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. PRM has an average financial health and profitability rating. PRM has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year PRM has reported negative net income.
PRM had a positive operating cash flow in the past year.
In multiple years PRM reported negative net income over the last 5 years.
PRM had a positive operating cash flow in 4 of the past 5 years.
PRM Yearly Net Income VS EBIT VS OCF VS FCFPRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.54%, PRM is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 10.96%, PRM is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 5.05%, PRM is in line with its industry, outperforming 51.76% of the companies in the same industry.
Industry RankSector Rank
ROA 5.54%
ROE 10.96%
ROIC 5.05%
ROA(3y)2.14%
ROA(5y)-3.4%
ROE(3y)4.47%
ROE(5y)-7.84%
ROIC(3y)N/A
ROIC(5y)N/A
PRM Yearly ROA, ROE, ROICPRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

The Profit Margin of PRM (23.23%) is better than 100.00% of its industry peers.
With an excellent Operating Margin value of 25.94%, PRM belongs to the best of the industry, outperforming 92.94% of the companies in the same industry.
The Gross Margin of PRM (56.54%) is better than 98.82% of its industry peers.
In the last couple of years the Gross Margin of PRM has grown nicely.
Industry RankSector Rank
OM 25.94%
PM (TTM) 23.23%
GM 56.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.47%
GM growth 5Y10.02%
PRM Yearly Profit, Operating, Gross MarginsPRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRM is destroying value.
The number of shares outstanding for PRM has been increased compared to 1 year ago.
The number of shares outstanding for PRM has been reduced compared to 5 years ago.
PRM has a better debt/assets ratio than last year.
PRM Yearly Shares OutstandingPRM Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
PRM Yearly Total Debt VS Total AssetsPRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 1.18, we must say that PRM is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of PRM (1.18) is worse than 70.59% of its industry peers.
PRM has a debt to FCF ratio of 4.14. This is a neutral value as PRM would need 4.14 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 4.14, PRM belongs to the best of the industry, outperforming 81.18% of the companies in the same industry.
PRM has a Debt/Equity ratio of 0.65. This is a neutral value indicating PRM is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.65, PRM perfoms like the industry average, outperforming 49.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 4.14
Altman-Z 1.18
ROIC/WACC0.59
WACC8.58%
PRM Yearly LT Debt VS Equity VS FCFPRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

PRM has a Current Ratio of 5.23. This indicates that PRM is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PRM (5.23) is better than 92.94% of its industry peers.
A Quick Ratio of 3.56 indicates that PRM has no problem at all paying its short term obligations.
PRM has a Quick ratio of 3.56. This is amongst the best in the industry. PRM outperforms 91.76% of its industry peers.
Industry RankSector Rank
Current Ratio 5.23
Quick Ratio 3.56
PRM Yearly Current Assets VS Current LiabilitesPRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

PRM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -933.33%.
PRM shows a strong growth in Revenue. In the last year, the Revenue has grown by 70.16%.
PRM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.58% yearly.
EPS 1Y (TTM)-933.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.26%
Revenue 1Y (TTM)70.16%
Revenue growth 3Y15.69%
Revenue growth 5Y18.58%
Sales Q2Q%21.99%

3.2 Future

The Earnings Per Share is expected to grow by 50.10% on average over the next years. This is a very strong growth
Based on estimates for the next years, PRM will show a small growth in Revenue. The Revenue will grow by 1.33% on average per year.
EPS Next Y210.43%
EPS Next 2Y80.24%
EPS Next 3Y50.1%
EPS Next 5YN/A
Revenue Next Year-5.52%
Revenue Next 2Y-0.43%
Revenue Next 3Y1.33%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PRM Yearly Revenue VS EstimatesPRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
PRM Yearly EPS VS EstimatesPRM Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PRM. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 10.77, which indicates a very decent valuation of PRM.
71.76% of the companies in the same industry are more expensive than PRM, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of PRM to the average of the S&P500 Index (22.10), we can say PRM is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 10.77
PRM Price Earnings VS Forward Price EarningsPRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

PRM's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, PRM is valued cheaper than 87.06% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.49
EV/EBITDA 10.96
PRM Per share dataPRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

PRM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PRM's earnings are expected to grow with 50.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y80.24%
EPS Next 3Y50.1%

More info and screens

0

5. Dividend

5.1 Amount

PRM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PERIMETER SOLUTIONS INC

NYSE:PRM (5/29/2025, 2:11:04 PM)

12.24

+0.27 (+2.26%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-08 2025-05-08/dmh
Earnings (Next)08-09 2025-08-09/bmo
Inst Owners87.18%
Inst Owner Change-2%
Ins Owners8.3%
Ins Owner Change-2.32%
Market Cap1.81B
Analysts80
Price Target16.32 (33.33%)
Short Float %2.47%
Short Ratio2.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)206.27%
Min EPS beat(2)98.02%
Max EPS beat(2)314.52%
EPS beat(4)3
Avg EPS beat(4)260%
Min EPS beat(4)-196.63%
Max EPS beat(4)824.09%
EPS beat(8)6
Avg EPS beat(8)194.95%
EPS beat(12)9
Avg EPS beat(12)162.36%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.98%
Min Revenue beat(2)-4.91%
Max Revenue beat(2)10.87%
Revenue beat(4)2
Avg Revenue beat(4)12.23%
Min Revenue beat(4)-4.91%
Max Revenue beat(4)43.99%
Revenue beat(8)5
Avg Revenue beat(8)16.22%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-2.13%
EPS NQ rev (3m)39.39%
EPS NY rev (1m)0.51%
EPS NY rev (3m)51.91%
Revenue NQ rev (1m)3.42%
Revenue NQ rev (3m)-2.2%
Revenue NY rev (1m)-0.28%
Revenue NY rev (3m)0.82%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.77
P/S 3.15
P/FCF 9.49
P/OCF 8.64
P/B 1.49
P/tB N/A
EV/EBITDA 10.96
EPS(TTM)-0.31
EYN/A
EPS(NY)1.14
Fwd EY9.28%
FCF(TTM)1.29
FCFY10.54%
OCF(TTM)1.42
OCFY11.58%
SpS3.89
BVpS8.23
TBVpS-4.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.54%
ROE 10.96%
ROCE 6.39%
ROIC 5.05%
ROICexc 5.52%
ROICexgc 57.84%
OM 25.94%
PM (TTM) 23.23%
GM 56.54%
FCFM 33.2%
ROA(3y)2.14%
ROA(5y)-3.4%
ROE(3y)4.47%
ROE(5y)-7.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.47%
GM growth 5Y10.02%
F-Score8
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 4.14
Debt/EBITDA 3.66
Cap/Depr 28.39%
Cap/Sales 3.27%
Interest Coverage 4.01
Cash Conversion 97.32%
Profit Quality 142.91%
Current Ratio 5.23
Quick Ratio 3.56
Altman-Z 1.18
F-Score8
WACC8.58%
ROIC/WACC0.59
Cap/Depr(3y)17.09%
Cap/Depr(5y)16.01%
Cap/Sales(3y)2.7%
Cap/Sales(5y)2.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-933.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.26%
EPS Next Y210.43%
EPS Next 2Y80.24%
EPS Next 3Y50.1%
EPS Next 5YN/A
Revenue 1Y (TTM)70.16%
Revenue growth 3Y15.69%
Revenue growth 5Y18.58%
Sales Q2Q%21.99%
Revenue Next Year-5.52%
Revenue Next 2Y-0.43%
Revenue Next 3Y1.33%
Revenue Next 5YN/A
EBIT growth 1Y214.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.71%
EBIT Next 3Y13.91%
EBIT Next 5YN/A
FCF growth 1Y1889.27%
FCF growth 3Y40.29%
FCF growth 5YN/A
OCF growth 1Y23622.2%
OCF growth 3Y37.57%
OCF growth 5YN/A